EBD Group Webinar this Tuesday

MetaCurUm has been awarded SEK 1 million from the Swedish Innovation Agency, Vinnova, under the "Acceleration of Deeptech Companies 2024" initiative.

Mentice has appointed Frans Venker as its new Chief Executive Officer, effective January 1, 2025.

The 11th edition of NLSDays is being held in Malmö on September 18-19. Program Director, Marjo Puumalainen, gives us an inside look into the upcoming conference.

Evaxion Biotech has announced new clinical phase 2 data for its lead compound EVX-01.

Lund University is establishing a university-wide development center for advanced therapies, LU-ATMP. Advanced Therapy Medicinal Products (ATMP) are medicines that are based on cells, tissues or genes. With ATMP, injuries and illnesses can be treated in completely new ways and provide better opportunities to relieve and, to a progressively greater extent, cure a wide range […]

A Finnish-led international research team has discovered novel gene variants that increase the risk of a rare but severe lung disease, idiopathic pulmonary fibrosis. The results also demonstrate notable genetic similarities with susceptibility to severe COVID-19 infection, reports HiLIFE. The study, led by the University of Helsinki, identified seven previously novel genetic risk factors. Only […]

An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from the Swedish Ethics Review Authority, and the team, led from Lund University is thereby ready to proceed with the trial, they state. […]